This unwanted iron elevation leads to mitochondrial dysfunction and age-related muscle atrophy
Furthermore, before considering SQOR-based therapies, it will be necessary to develop companion diagnostic tools to assess SQOR activity in a patients tissues and determine how dependent cell survival is on SQOR, thereby guiding whether to inhibit or activate SQOR to achieve the desired therapeutic outcome
Clinical trials show an average of 510% body weight reduction by week 12, which could be 1015+ pounds for some people
AMSTAR 2 assessments indicate that the existing evidence is limited by methodological shortcomings, including incomplete reporting of excluded studies, suboptimal literature search strategies, and insufficient evaluation of how bias in primary studies may influence meta-analytic estimates
Your goals, health status, and side effect tolerance determine the right approach